HMGN2P34

Across TCGA pan-cancer cohorts, HMGN2P34 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of HMGN2P34’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where HMGN2P34 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types HMGN2P34 is over-expressed in tumor.

LUAD, BRCA, and LUSC are the cancer types where HMGN2P34 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HMGN2P34 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	II,III,IV	+0.132	.021	4	view →
BRCA	All	All	+0.057	<.001	4	view →
LUSC	All	All	+0.096	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

HMGN2P34–LUAD

Open the LUAD breakdown →